S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
Log in

Allied Properties Real Estate Investment (TSE:AP.UN) Declares Dividend Increase - $0.14 Per Share

Tuesday, February 23, 2021 | MarketBeat

Allied Properties Real Estate Investment (TSE:AP.UN) declared a monthly dividend on Thursday, February 25th, TickerTech reports. Stockholders of record on Monday, March 15th will be given a dividend of 0.1417 per share by the real estate investment trust on Monday, March 15th. This represents a $1.70 annualized dividend and a dividend yield of 4.74%. The ex-dividend date is Thursday, February 25th. This is a positive change from Allied Properties Real Estate Investment's previous monthly dividend of $0.14.

AP.UN stock opened at C$35.89 on Tuesday. The firm's fifty day simple moving average is C$37.24 and its two-hundred day simple moving average is C$37.50. The stock has a market capitalization of C$4.57 billion and a price-to-earnings ratio of 8.93. The company has a quick ratio of 0.27, a current ratio of 0.36 and a debt-to-equity ratio of 47.10. Allied Properties Real Estate Investment has a twelve month low of C$31.49 and a twelve month high of C$59.54.

Several research firms recently weighed in on AP.UN. Raymond James restated an "outperform" rating and issued a C$48.00 price objective on shares of Allied Properties Real Estate Investment in a report on Thursday, February 4th. CIBC increased their target price on Allied Properties Real Estate Investment from C$43.00 to C$44.00 and gave the company an "outperform" rating in a research report on Friday, February 5th. BMO Capital Markets upped their price objective on Allied Properties Real Estate Investment from C$40.00 to C$42.25 in a research note on Monday, December 14th. National Bank Financial reduced their target price on shares of Allied Properties Real Estate Investment from C$54.00 to C$48.00 and set an "outperform" rating for the company in a report on Monday, November 2nd. Finally, TD Securities lowered their target price on shares of Allied Properties Real Estate Investment from C$52.00 to C$45.00 and set a "buy" rating for the company in a research note on Friday, October 30th. Five investment analysts have rated the stock with a buy rating, Allied Properties Real Estate Investment currently has a consensus rating of "Buy" and an average target price of C$46.84.

In other Allied Properties Real Estate Investment news, Director Michael R. Emory bought 1,458 shares of Allied Properties Real Estate Investment stock in a transaction dated Thursday, February 18th. The stock was acquired at an average cost of C$35.87 per share, with a total value of C$52,298.46. Following the purchase, the director now directly owns 228,281 shares in the company, valued at approximately C$8,188,439.47.

About Allied Properties Real Estate Investment

Allied is a leading owner, manager and developer of (i) distinctive urban workspace in Canada's major cities and (ii) network-dense urban data centres in Toronto that form Canada's hub for global connectivity. Allied's business is providing knowledge-based organizations with distinctive urban environments for creativity and connectivity.

Featured Story: Outstanding Shares and The Effect on Share Price

Dividend History for Allied Properties Real Estate Investment (TSE:AP.UN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]


15 Healthcare Stocks that Analysts Love

There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutical companies, medical research firms, hospital systems, and other healthcare stocks, it can be hard to identify which healthcare companies will outperform the market.

Fortunately, Wall Street's brightest minds have already done this for us. Every year, analysts issue approximately 3,000 distinct recommendations for healthcare companies. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firms are giving "strong-buy" and "buy" ratings to the same healthcare stock.

This slide show lists the 15 healthcare companies with the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.

View the "15 Healthcare Stocks that Analysts Love".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.